aeras-oxford-university-okairos-get-usd2

Bill Gates pays $2.9mn for TB, malaria, HIV vaccine

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aeras, a nonprofit biotech firm that is advancing TB vaccines, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell... Read more

japan-based-irom-holdings-will-acquire-18

Japanese I’rom acquires 18% in Australian IDT

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading... Read more

in-the-line-of-fire-pawan-bansal-s-family-run-pharma-business-may-now-be-under-scanner

Pawan Bansal's family-run pharma firm also involved in scams?...

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: It seems like the troubles for India's Union Cabinet Minister for Railways, Mr Pawan Kumar Bansal, may not have subsided yet. Although the case of Mr... Read more

prof-sirirurg-songsivilai-of-national-nanotechnology-center-nanotec-thailand-says-that-the-government-will-spend-usd70-million-to-promote-development-of-medical-robots-and-regenerative-medicine

Thailand to spend $70mn to develop medical robots

  • Thailand
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Thailand, which has been leading delegations and participating as an exhibitor in BIO International Convention for the past several years, emerged as... Read more

american-college-of-chest-physicians-accp-update-guidelines-on-lung-cancer

Physicians update cancer screening guidelines

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The American College of Chest Physicians (ACCP) has recommended that people, who are being screened for lung cancer and already face a significant risk... Read more

us-fda-designates-abbvie-s-hepatitis-c-treatment-as-breakthrough-therapy

FDA: AbbVie Hepatitis therapy is a 'breakthrough'

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatment of genotype (GT1) hepatitis C virus (HCV)... Read more

heartbeat-experts-reports-350-percent-growth-in-emerging-markets-such-as-brazil-russia-india-china-and-south-korea-brick-markets

Heartbeat reports 350% growth in emerging markets

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, has reported 350 percent year-over-year growth... Read more

us-fda-approves-cervarix-for-use-in-females-aged-nine-to-25-years

Now 9-yr-old girls can use Cervarix for cancer

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical lesions and cervical cancer... Read more

veolia-expands-water-treatment-operations-in-new-singapore-bioscience-facility

Veolia expands in new Singapore bioscience facility

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Veolia Water Solutions and Technologies is expanding its existing water treatment facilities for the second phase of a new bioscience facility in Singapore.... Read more

merck-received-us-fda-approval-for-liptruzet-ezetimibe-and-atorvastatin-tablets-for-elevated-low-density-lipoprotein-ldl-cholesterol

Merck gets US FDA nod for cholesterol drug

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merck, also known as MSD outside the US and Canada, received US FDA approval for Liptruzet (ezetimibe and atorvastatin) tablets for the treatment of elevated... Read more

janssen-pharma-a-johnson-johnson-company-recalled-170-batches-of-children-s-dye-free-tylenol-suspension-as-they-contained-a-higher-concentration-of-liver-toxin-acetaminophen

Janssen faces suspension in S Korea, recalls drug

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Janssen Pharma, which is member of the Johnson&Johnson (J&J) group of companies, South Korean unit has been ordered to stop manufacturing of two types... Read more

regeneron-acquires-rights-to-sanofi-s-ophthalmology-antibodies-targeting-the-pdgf-platelet-derived-growth-factor-and-ang2-angiopoietin2

Regeneron acquires Sanofi eye care antibodies

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from Sanofi. Regeneron acquired full rights to antibodies... Read more

new-virus-called-novel-coronavirus-ncov-kills-five-people-in-saudi-arabia

New coronavirus kills 5 in Saudi Arabia

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Saudi Arabia Ministry of Health has seven new laboratory confirmed cases of infection dealing with the novel coronavirus (nCoV), including five deaths.... Read more

australia-is-adopting-antiangiogenesis-therapy-and-spectral-domain-optical-coherence-tomography-sd-oct-to-counter-age-related-macular-degeneration-amd

No of AMD patients to reach 1.7 mn by 2030 in Aus

  • Australia
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The number of Australians with age-related macular degeneration (AMD) is expected to grow to over 1.7 million by 2030, yet many patients do not currently... Read more

bristol-myers-squibb-bms-received-us-fda-s-approval-for-its-supplemental-new-drug-application-snda-for-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-sustiva-efavirenz

BMS 'capsule sprinkle' HIV drug gets US FDA nod

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bristol-Myers Squibb (BMS) received US FDA's approval for a supplemental new drug application (sNDA) for Sustiva (efavirenz), including dosing recommendations... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X